Literature DB >> 25403901

Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling.

Lacey A Smith1, Jessica Douglas, Alicia A Braxton, Kate Kramer.   

Abstract

The purpose of this study was to investigate how the American College of Medical Genetics and Genomics (ACMG) March 2013 recommendations for reporting incidental findings (IFs) have influenced current practices of genetic counselors involved in utilizing whole exome sequencing (WES) for clinical diagnosis. An online survey was sent to all members of the National Society of Genetic Counselors; members were eligible to participate if they currently offered WES for clinical diagnosis. Forty-six respondents completed the survey of whom 34 were in practice prior to the March 2013 ACMG recommendations. Half of respondents (N = 19, 54.9 %) in practice prior to March 2013 reported that the ACMG recommendations have had a significant impact on the content of their counseling sessions. Approximately half of respondents (N = 21, 45.5 %) report all IFs, regardless of patient age, while one third (N = 14, 30.4 %) consider factors such as age and parent preference in reporting IFs. Approximately 40 % (N = 18) of respondents reported that the testing laboratory's policy for returning IFs has an influence on their choice of laboratory; of those, 72.2 % (N = 13) reported that the option to opt out of receiving reports of IFs has a significant influence on their choice of laboratory. A majority of respondents (N = 43, 93.5 %) found that most patients want to receive reports of IFs. However, respondents report there are patients who wish to decline receiving this information. This study querying genetic counselors identified benefits and challenges that the 2013 ACMG recommendations elicited. Some challenges, such as not having the option to opt out of IFs, have been addressed by the ACMG's most recent updates to their recommendations. Further investigation into larger and more inclusive provider populations as well as patient populations will be valuable for the ongoing discussion surrounding IFs in WES.

Entities:  

Mesh:

Year:  2014        PMID: 25403901     DOI: 10.1007/s10897-014-9794-4

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  18 in total

1.  Challenges in the clinical application of whole-genome sequencing.

Authors:  Kelly E Ormond; Matthew T Wheeler; Louanne Hudgins; Teri E Klein; Atul J Butte; Russ B Altman; Euan A Ashley; Henry T Greely
Journal:  Lancet       Date:  2010-04-29       Impact factor: 79.321

2.  To know or not to know? Genetic ignorance, autonomy and paternalism.

Authors:  Jane Wilson
Journal:  Bioethics       Date:  2005-10       Impact factor: 1.898

3.  Reporting genomic sequencing results to ordering clinicians: incidental, but not exceptional.

Authors:  Robert C Green; James R Lupski; Leslie G Biesecker
Journal:  JAMA       Date:  2013-07-24       Impact factor: 56.272

4.  Views of genetics health professionals on the return of genomic results.

Authors:  Megan E Grove; Maya N Wolpert; Mildred K Cho; Sandra Soo-Jin Lee; Kelly E Ormond
Journal:  J Genet Couns       Date:  2013-06-02       Impact factor: 2.537

5.  Attitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing.

Authors:  Joon-Ho Yu; Tanya M Harrell; Seema M Jamal; Holly K Tabor; Michael J Bamshad
Journal:  Am J Hum Genet       Date:  2014-06-26       Impact factor: 11.025

6.  Exploring concordance and discordance for return of incidental findings from clinical sequencing.

Authors:  Robert C Green; Jonathan S Berg; Gerard T Berry; Leslie G Biesecker; David P Dimmock; James P Evans; Wayne W Grody; Madhuri R Hegde; Sarah Kalia; Bruce R Korf; Ian Krantz; Amy L McGuire; David T Miller; Michael F Murray; Robert L Nussbaum; Sharon E Plon; Heidi L Rehm; Howard J Jacob
Journal:  Genet Med       Date:  2012-03-15       Impact factor: 8.822

7.  Incidental findings in clinical genomics: a clarification.

Authors: 
Journal:  Genet Med       Date:  2013-07-04       Impact factor: 8.822

8.  Genetic incidental findings: autonomy regained?

Authors:  Effy Vayena; John Tasioulas
Journal:  Genet Med       Date:  2013-08-01       Impact factor: 8.822

9.  Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing.

Authors:  Layla Shahmirzadi; Elizabeth C Chao; Erika Palmaer; Melissa C Parra; Sha Tang; Kelly D Farwell Gonzalez
Journal:  Genet Med       Date:  2013-10-10       Impact factor: 8.822

10.  Technical report: Ethical and policy issues in genetic testing and screening of children.

Authors:  Lainie Friedman Ross; Laine Friedman Ross; Howard M Saal; Karen L David; Rebecca R Anderson
Journal:  Genet Med       Date:  2013-02-21       Impact factor: 8.822

View more
  11 in total

Review 1.  Insights from exome sequencing for endocrine disorders.

Authors:  Christiaan de Bruin; Andrew Dauber
Journal:  Nat Rev Endocrinol       Date:  2015-05-12       Impact factor: 43.330

2.  Incidental or secondary findings: an integrative and patient-inclusive approach to the current debate.

Authors:  Marlies Saelaert; Heidi Mertes; Elfride De Baere; Ignaas Devisch
Journal:  Eur J Hum Genet       Date:  2018-07-03       Impact factor: 4.246

3.  Experiences and lessons learned by genetic counselors in returning secondary genetic findings to patients.

Authors:  Carly Rost; Karin M Dent; Jeffrey Botkin; Erin Rothwell
Journal:  J Genet Couns       Date:  2020-05-26       Impact factor: 2.537

4.  A comparison of genomic diagnostics in adults and children with epilepsy and comorbid intellectual disability.

Authors:  Norman Delanty; Gianpiero L Cavalleri; Katherine A Benson; Maire White; Nicholas M Allen; Susan Byrne; Robert Carton; Elizabeth Comerford; Daniel Costello; Colin Doherty; Brendan Dunleavey; Hany El-Naggar; Nisha Gangadharan; Sinéad Heavin; Hugh Kearney; Nicholas J Lench; John Lynch; Mark McCormack; Mary O' Regan; Karl Podesta; Kevin Power; Anthony S Rogers; Charles A Steward; Brian Sweeney; David Webb; Mary Fitzsimons; Marie Greally
Journal:  Eur J Hum Genet       Date:  2020-04-01       Impact factor: 4.246

5.  A protocol for the identification and validation of novel genetic causes of kidney disease.

Authors:  Andrew Mallett; Chirag Patel; Barbara Maier; Julie McGaughran; Michael Gabbett; Minoru Takasato; Anne Cameron; Peter Trnka; Stephen I Alexander; Gopala Rangan; Michel C Tchan; Georgina Caruana; George John; Cathy Quinlan; Hugh J McCarthy; Valentine Hyland; Wendy E Hoy; Ernst Wolvetang; Ryan Taft; Cas Simons; Helen Healy; Melissa Little
Journal:  BMC Nephrol       Date:  2015-09-15       Impact factor: 2.388

6.  Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meet.

Authors:  Joanne Ngeow; Charis Eng
Journal:  NPJ Genom Med       Date:  2016-01-13       Impact factor: 8.617

7.  Diagnostic use of Massively Parallel Sequencing in Neuromuscular Diseases: Towards an Integrated Diagnosis.

Authors:  Valérie Biancalana; Jocelyn Laporte
Journal:  J Neuromuscul Dis       Date:  2015-09-02

8.  Criteria for reporting incidental findings in clinical exome sequencing - a focus group study on professional practices and perspectives in Belgian genetic centres.

Authors:  Marlies Saelaert; Heidi Mertes; Tania Moerenhout; Elfride De Baere; Ignaas Devisch
Journal:  BMC Med Genomics       Date:  2019-08-20       Impact factor: 3.063

Review 9.  Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.

Authors:  Michael P Mackley; Benjamin Fletcher; Michael Parker; Hugh Watkins; Elizabeth Ormondroyd
Journal:  Genet Med       Date:  2016-09-01       Impact factor: 8.822

10.  An ancestry informative marker panel design for individual ancestry estimation of Hispanic population using whole exome sequencing data.

Authors:  Li-Ju Wang; Catherine W Zhang; Sophia C Su; Hung-I H Chen; Yu-Chiao Chiu; Zhao Lai; Hakim Bouamar; Amelie G Ramirez; Francisco G Cigarroa; Lu-Zhe Sun; Yidong Chen
Journal:  BMC Genomics       Date:  2019-12-30       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.